Access cutting-edge liver cancer treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This is a Phase III, randomised, open-label, sponsor-blinded, 3-arm, multicentre, global study assessing the efficacy and safety of rilvegostomig in combination with bevacizumab with or without tremelimumab compared to atezolizumab in combination with bevacizumab. This study will be conducted in participants with advanced HCC who are not amenable to curative therapy or locoregional therapy
Sponsor: AstraZeneca
Check if you qualify for this liver cancer clinical trial in New Haven, CT
If you're searching for liver cancer treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.